Canine parvovirus (CPV) is the number one viral cause of enteritis, morbidity, and mortality in 8-week-old young puppies. We have developed twin assays (slide agglutination test [SAT] for CPV antigen and slide inhibition test [SIT] for CPV antibody) that are sensitive, specific, cost-effective, generic for all genotypes of CPV, and provide instant results for CPV antigen detection in feces and antibody quantification in serum. We found these assays to be useful for routine applications in kennels with large numbers of puppies at risk. The results of these assays are available in 1 min and do not require any special instrumentation. SAT-SIT technology will find applications in rapid screening of samples for other hemagglutinating emerging viruses of animals and humans (influenza virus and severe acute respiratory syndrome coronavirus).Canine parvovirus (CPV) is the number one viral cause of puppy enteritis and mortality (8). Unique properties of CPV make it an emerging and reemerging pathogen of dogs worldwide (2,5,16,17). Parvoviruses have a single-stranded DNA genome of 5,000 bases with a hairpin structure (4). Parvoviruses have exceptional evolutionary ability (10). Parvoviruses are extremely stable in the environment and relatively resistant to disinfectants because they are nonenveloped viruses (19). CPV multiplies in the rapidly dividing cells in the crypts of the intestine, leading to diarrhea and dehydration (4).In the kennel environment, the availability of a large number of susceptible puppies, environmental stress, and unique properties of CPV combine to form an ideal scenario for the rapid spread of CPV. Effective commercial modified live virus vaccines that vary in the genotype (CPV type 2 [CPV-2] and CPV-2b) of CPV in the vaccine are available. There is currently no commercial vaccine with CPV-2c in the vaccine. However, induction of active immunity in puppies is blocked by maternal immunity in the puppies (18). The stability of CPV in the kennel environment and excretion of large amounts of CPV by sick puppies can expose susceptible puppies to massive infectious doses of CPV. This CPV susceptibility window coincides with weaning in puppies in the age group of about 6 to 8 weeks old. Eight weeks is the age when the largest number of puppies succumb to CPV. Moreover, there are variations in the decay of antibodies and induction of active immunity after vaccination directed by the genetic makeup (canine major histocompatibility antigens) of the puppies.It would be clinically useful if there were diagnostic tests that could detect the amount of CPV in a sample, genotype the virus, and quantify the antibodies against different CPV subtypes quickly in the kennel environment. With this goal, we have developed and validated instant CPV antigen and antibody tests (slide agglutination test [SAT] for CPV antigen and slide inhibition test [SIT] for CPV antibody in serum). These tests are instant (real time), sensitive, quantitative, and generic for all the CPV types. We are confident that these safe, econo...